- Home
- ENZ vs ALGS Comparison
ENZ vs ALGS Comparison
Compare ENZ & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENZ
- ALGS
- Stock Information
- Founded
- ENZ 1976
- ALGS 2018
- Country
- ENZ United States
- ALGS United States
- Employees
- ENZ N/A
- ALGS N/A
- Industry
- ENZ Medical Specialities
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- ENZ Health Care
- ALGS Health Care
- Exchange
- ENZ Nasdaq
- ALGS Nasdaq
- Market Cap
- ENZ 34.2M
- ALGS 38.8M
- IPO Year
- ENZ N/A
- ALGS 2020
- Fundamental
- Price
- ENZ $0.31
- ALGS $7.14
- Analyst Decision
- ENZ
- ALGS Strong Buy
- Analyst Count
- ENZ 0
- ALGS 1
- Target Price
- ENZ N/A
- ALGS $70.00
- AVG Volume (30 Days)
- ENZ 170.1K
- ALGS 140.5K
- Earning Date
- ENZ 03-17-2025
- ALGS 03-10-2025
- Dividend Yield
- ENZ 30.68%
- ALGS N/A
- EPS Growth
- ENZ N/A
- ALGS N/A
- EPS
- ENZ N/A
- ALGS N/A
- Revenue
- ENZ $29,094,000.00
- ALGS $3,945,000.00
- Revenue This Year
- ENZ N/A
- ALGS $580.86
- Revenue Next Year
- ENZ N/A
- ALGS N/A
- P/E Ratio
- ENZ N/A
- ALGS N/A
- Revenue Growth
- ENZ N/A
- ALGS N/A
- 52 Week Low
- ENZ $0.31
- ALGS $6.76
- 52 Week High
- ENZ $1.30
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- ENZ 22.66
- ALGS 24.28
- Support Level
- ENZ $0.31
- ALGS $10.45
- Resistance Level
- ENZ $0.50
- ALGS $9.76
- Average True Range (ATR)
- ENZ 0.04
- ALGS 1.11
- MACD
- ENZ -0.01
- ALGS 0.15
- Stochastic Oscillator
- ENZ 18.23
- ALGS 2.13
About ENZ Enzo Biochem Inc. ($0.01 Par Value)
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.